Abstract: Potentially inappropriate prescriptions (PIP) is drug treatment, which in general, at the group level for a median/mean patient, can be considered unfavourable meaning that the risks commonly may outweigh the benefits. This MiniReview reports and discusses the main findings in a large cluster-randomized educational intervention in Norwegian general practice, aimed at reducing the prevalence of PIPs to patients ≥70 years (The Rx-PAD study). Targets for the intervention were general practitioners (GPs) in continuing medical education (CME) groups receiving educational outreach visits (i.e. peer academic detailing). A Delphi consensus process, with a panel of medical experts, was undertaken to elaborate a list of explicit criteria defining PIPs for patients ≥70 years in general practice. Agreement was achieved for 36 explicit PIP criteria, the so-called Norwegian General Practice (NorGeP) criteria. Using a selection (n = 24) of these criteria during a 1-year baseline period on the prescribing practice of 454 GPs (i.e. those enrolled to participate in the intervention trial), we found a prevalence rate of 24.7 PIPs per 100 patients ≥70 years per year. In the Rx-PAD study, 449 GPs completed an educational intervention (96.6% of the included GPs), 250 in the intervention group and 199 in the control arm. Following the intervention, PIPs were reduced by 13% (95% CI 8.6-17.3), and the number of patients who were no longer exposed to one or more PIPs was reduced by 1173 (8.1%). The GPs who responded most strongly to the educational intervention were the oldest GPs (57-68 years), and these were the GPs with the highest prevalence of PIPs at baseline before the intervention.
In this MiniReview, we summarize the doctoral thesis by Rognstad: Inappropriate prescribing to older patients: criteria, prevalence and an intervention to reduce it: The Prescription Peer Academic Detailing (Rx-PAD) study -A clusterrandomized, educational intervention in Norwegian general practice, which was based on three articles [1] [2] [3] .
There were three main objectives in this thesis: (1) to define and develop a clinically relevant list of explicit criteria for pharmacologically, potentially inappropriate prescriptions (PIPs) to patients aged ≥70 years in general practice. 'Potentially Inappropriate Prescriptions' refers to the prescriptions of single drugs and combination of drugs as they are collected from the Norwegian Prescription Database (NorPD) [4] . It does not refer to drugs actually taken by the patients. This was done through a Delphi consensus process by a multidisciplinary panel of medical experts [2] ; (2) to estimate the prevalence of PIPs according to a selection of these criteria in patients aged ≥70 years in a general practice setting [3] ; and (3) to undertake a multifaceted, educational intervention to improve GPs' prescribing practice for patients aged ≥70 years using the prevalence of PIPs as the main outcome measure [1, 5] .
Although appropriate use of drugs is of vital importance to older patients, multimorbidity, with consequent polypharmacy, makes prescribing particularly challenging in this population. Both pharmacokinetics and pharmacodynamics are altered in the elderly as compared to younger adults. Adverse outcome of drug use may result in impaired quality of life, increased morbidity and even death [6] . A comprehensive Norwegian study found that one in six deaths in a medical department was caused by the drug treatment rather than by the disease and that those most at risk were elderly people using many drugs and who had had high comorbidity [6] . In a study from Sweden, fatal adverse drug reactions (ADRs) accounted for approximately 3% of all deaths in the general Author for correspondence: Sture Rognstad, Department of General Practice, Institute of Health and Society, University of Oslo, P.O. Box 1130, Blindern, N-0318 Oslo, Norway (e-mail: sture.rognstad@medisin.uio.no).
population, and ADRs were the seventh most common cause of death [7] .
ADR can be defined as: 'An appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment, or alteration of the dosage regimen, or withdrawal of the product'. Most of ADRs (80%) are dose-related and predictable [8] .
In a meta-analysis of prospective studies in US hospitals, Lazarou et al. [9] found a total annual incidence of serious and fatal ADRs of 6.7% and 0.3%, respectively. This makes ADRs the fourth leading cause of death in the USA, following heart disease, cancer and stroke. This meta-analysis included hospitalized patients with an average age of 50.4 years and was not limited to elderly patients. A more recent review confirmed that one in ten hospital admissions in older patients are due to ADRs, NSAIDs being the group of medication most related to these admissions [10] . ADR prevalence figures like these need to be interpreted with awareness of their providing a one-sided perspective on drug treatment. Indeed, they reflect the risks but not the benefits. Further, ADRs are often differential diagnoses, and causal relationships can seldom be firmly established. Nevertheless, ADRs are undesirable for the patient and the health care.
Potentially inappropriate drug treatment includes use of drugs or combinations of drugs with potential of unwanted effects. However, even if such prescribing is considered potentially inappropriate at a group level, it may be considered a proper treatment to a specific patient, with a specific medical condition in a specific clinical setting. This, because each patient is unique and elderly patients often present complex medical problems requiring tailored and individual treatment. A list of PIPs must therefore be considered as rules of the thumb for safer prescribing practice.
PIPs may be quantified in several ways: as number of PIPs per patient [11] or per prescription [12] or as the proportion of patients who receive one or more PIPs per time period [13] . One tool widely used for many years to define PIPs for elderly patients is the Beers criteria with updates [14, 15] . These are explicit criteria, defining PIPs in three categories: (1) medications or medication categories that generally should be avoided because they are either ineffective or may pose an unnecessary high risk for older people; (2) doses, frequencies or durations of therapies that are not in accordance with current guidelines and recommendations; and (3) medications that should not be used in persons known to have particular medical conditions, even though their use in the general elderly population might be appropriate. Lately, several lists of criteria for PIPs have been published, START/STOPP from Ireland in 2007 [16, 17] , updated in 2015 [18] , the PRISCUS list from Germany [19] and the EU(7)-PIM list from 2015 [20] .
Most of these published lists have also focused on potentially pharmacological inappropriateness, based on explicit criteria for drugs or combinations of drugs to avoid [21] . Most of them are based on consensus rather than on evidence. In a systematic review of criteria for inappropriate prescriptions, Kaufmann et al. [22] found that out of 46 published tools for defining inappropriate prescriptions, 41% were based on comprehensive consensus methods while the rest were based on literature reviews or simple expert panels. However, it is still open for debate if such criteria actually reflect the quality of prescribing. Several studies published throughout the last years have questioned the external validity of explicit criteria for PIPs. Measured up against a gold standard, most criteria have a low sensitivity (between 30% and 40%) and have therefore a low external validity [23] [24] [25] .
The prevalence of inappropriate prescribing for elderly patients in general practice has been reported to be between 14% and 23% of all prescriptions [26, 27] . However, direct comparison is hampered because the studies apply different criteria for inappropriateness [28] . With the expected demographic shift towards more elderly patients with several concurrent chronic illnesses, we can expect the risk of PIPs to rise in the years to come.
One of the main research questions in the present study was whether it was possible to improve GPs' prescribing practice for patients aged ≥70 years through an educational intervention. Previously, several barriers have been identified when it comes to changing GPs' prescribing patterns [29, 30] . Flottorp et al. [30] identified the following barriers to implementing guidelines for the treatment of urinary tract infections and sore throat in a GP setting: loss of income by following guidelines (money); fear of overlooking serious disease by implementing the guidelines (play safe); patients expected a certain treatment (patients' preferences); and not enough time to read the printed information (time). In addition, three main barriers to implementation of clinical guidelines were listed by Cabana et al. [31] . Firstly, an increasing number of guidelines make it difficult for any physician to be aware of new guidelines and apply them to their practice. Secondly, physicians may lack familiarity with the guidelines and the relevant knowledge to apply them correctly. Thirdly, physicians may not concur with a specific guideline or even the concept of guidelines in general.
Although several attempts to explain GPs' decision-making during prescribing have been based on drug-related factors, it is important to remember that other factors may be important, such as doctors' characteristics, influence from hospital-based prescribers [32] and the pharmaceutical industry [33] , as well as patients' demands and expectations [30, 34] . A GP's questioning of a guideline and its evidence base (e.g. because of narrow inclusion criteria and questionable external validity) may also be a barrier to adherence. In addition to the GPrelated characteristics (e.g. sex, age, skills, habits, and attitudes), organizational factors, such as the activity of their practice (e.g. number of patients seen by the GP each day), available resources, structures, time and money, may also represent important barriers to overcome when changes of practice are to be implemented.
In a 1995 review, Oxman et al. [35] concluded that there are no 'magic bullets' when it comes to methods for improving clinical practice. Conferences and lectures, printed material or local opinion leaders (often used by the pharmaceutical companies) seem to have little, if any, effect [35] . The method of audit and feedback has, however, been found to lead to small but potentially important improvements in professional practice [36, 37] . The effectiveness of this method seems to depend on baseline performance and how feedback and recommendations are provided [37] . Even if systematic reviews have confirmed that audit and feedback by academic detailing (AD) have an impact on prescribing practice, the reported effects vary [38] [39] [40] . An independent health professional, visiting other health professionals in their own setting, is the core principle of academic detailing. The process of AD involves face-to-face education of prescribers by trained healthcare professionals, typically by a physician, a pharmacist or a qualified nurse. AD may be a visit to an individual or a group of GPs. AD may also be just one component of a multifaceted intervention that includes reminders or audit and feedback procedures. In Denmark, the Institute for Rational Pharmacotherapy has practised AD for several years [41] . Although some studies find little, if any, effect of AD on prescribing practice, others report that AD, alone, or in combination with other interventions, improves prescribing practice [42] . Previous educational intervention studies on GPs' prescribing have mainly focused on a limited spectrum of PIPs, for example, antibiotics, antidepressants [43] or NSAIDs [44] , or on prescribing costs [45] . Few studies have focused on a broad spectrum of PIP criteria across a wide range of therapeutic fields. To assess the effect of an educational intervention, as in the Rx-PAD study, it is important to include a broad spectrum of different PIP criteria; otherwise, the effect of the intervention will be highly dependent on the selected criteria within a particular therapeutic area.
Relevant aspects of the methods, results and discussion of the Rx-PAD study are reviewed in the following sections.
Criteria for PIPs (The NorGeP Criteria)
Methods and results.
In the first step of creating a list of clinically relevant PIP criteria for patients ≥70 years in general practice, four medical professors at University of Oslo (general practice, clinical pharmacology and geriatrics) suggested a list of 37 explicit criteria based on their own clinical experience, as well as the Beers criteria with updates [14, 15, 46] , Swedish recommendations, a previous Norwegian study [26] and more recent evidence from the literature [47] (tables 1 and 2).
To elaborate the final list, we used a modified three-round Delphi technique [48] , where 140 physicians were invited to participate. They were specialists in either geriatrics, clinical pharmacology or general practice. Out of the 140 experts invited, 57 accepted the invitation and completed the first round, 50 completed two rounds, and 47 (14 clinical pharmacologists, 17 geriatricians and 16 GP specialists) completed all three rounds. Each panellist scored the clinical relevance (on a visual analogue scale from 0 to 100) for each of the 37 criteria.
After the first round of the Delphi process, the participants received feedback including their previous own score, along with the mean score (with standard deviations) for the whole, Table 1 . Twenty-one potentially inappropriate prescriptions of single drugs presented to the expert panel in the NorGeP study of which 18 were also used in the Rx-PAD study.
Criterion no
Single drug Used in the Rx-PAD study Comments (valid for criterion numbers) as well as the participants' comments to the proposed criteria. The panellists were then asked to score the clinical relevance of each criterion once again. This procedure was repeated for three rounds. In both first and second round, the panellists were also invited to suggest additional criteria. We then analysed the scores for each criterion regarding potential inappropriateness and the agreement within the panel. Inappropriateness was considered relevant if the median score fell within the upper third (66.7-100.0) of the range, and irrelevant if it fell within the lower third (0-33.3) of the range. For each criterion, the interquartile range (IQR) was calculated. The IQR is a measure of statistical dispersion and was therefore used as a measure of agreement. Prior to the process, agreement was defined as existing if the IQR fell within any one-third range of the scale. The panel agreed that 36, out of the 37 suggested criteria for pharmacological inappropriateness, were clinically relevant in general practice for patients aged ≥70 years. One criterion, namely the combination of macrolides (erythromycin and clarithromycin) and digitoxin (criterion no. 31, table 2), did not meet the predefined conditions for being included on the list (median score of 65.3 and IQR 20.0). The criterion with the lowest score for clinical relevance was the combination of NSAIDs and SSRI (median score 68.0 and IQR 20.0), while the concomitant use of three or more psychotropic drugs scored highest for clinical relevance (median score 95.0), with a high degree of agreement (IQR 10.0). Over the three Delphi process rounds, the geriatrician group showed the highest internal agreement, while most disagreement was seen among the GPs. The resulting list constitutes the Norwegian General Practice (NorGeP) criteria [2] .
Prevalence of PIPs to Patients ≥70 years in General Practice
Methods and results. This prevalence study [3] was based on 1-year (year 2005) baseline prescription data from 454 GPs who had been recruited to participate in an educational intervention study, the prescription peer academic detailing (Rx-PAD) study [1, 5] . The prescribing practices of the included GPs were measured against a list of 24 PIP criteria developed by the research group, in collaboration with 13 GPs who would serve as peer academic detailers (PADs) in the forthcoming Rx-PAD intervention study. The PIP criteria used here were, in fact, a selection of the NorGeP criteria resulting from the Delphi process. Criteria involving antibiotics were omitted because more appropriate antibiotic prescribing practice for respiratory tract infections should be the target for an educational intervention running in the control arm of the Rx-PAD study [1] . For reasons of feasibility, some other criteria (e.g. regarding diazepam, oxazepam and zopiclone) were not included.
The 24 included PIPs comprised 18 single drugs and six combinations of drugs (tables 1 and 2). They were arranged in groups within the same therapeutic field, resulting in a list of 13 criteria for PIPs. Prescriptions by all the participating GPs were recorded for a 12-month period (1 January-31 December 2005). Data were extracted from the Norwegian Prescription Database (NorPD) [4] which contains all prescription drugs dispensed by pharmacies in Norway since 2004.
For each of the 18 single-drug criteria (table 1) , a prescription for that medication within 1 year was defined as one 'hit' for that patient. Repeat prescriptions for the same drug during the observation period did not add up to more hits. For the six drug-drug combinations (table 2), prescription of a listed combination of drugs within the same month, or estimated concurrent use over a period of 1 month or more, was also defined as one 'hit'. Duration of use was based on prescribed amounts (defined daily doses or DDDs) [1] . Concomitant use of three or more psychotropic drugs was defined as one 'hit' when the prescribed amounts of the drugs indicated concurrent use over a period of at least 3 months.
The unit of analysis was each doctor's level of PIPs per 100 patients ≥70 years. The impact of GP characteristics was examined using the multiple linear regression analysis, and the bivariate correlation between continuous variables was assessed by Pearson's correlation coefficient. SPSS version 14 was used for statistical analysis. The level of statistical significance was set to 5%. This prevalence study and the main Rx-PAD trial (described in detail later) were both approved by the Regional Committee for Research Ethics in Norway. Approval was also obtained from the Norwegian Social Science Data Services. The Directorate for Health and Social Affairs approved an exemption from the Health Professional Secrecy regulations. All patient data were linked to de-identified ID numbers.
The results of the 1-year data collection period showed that the 454 GPs wrote one or more prescriptions for almost 86,000 patients ≥70 years of age. Close to 22,000 (2.1%) out of 1,034,034 prescriptions concerned PIPs according to the chosen criteria, corresponding to 24.7 per 100 patients ≥70 years (table 3) . Of the patients with PIPs, 7.3% had been issued a tricyclic antidepressant or a first-generation antipsychotic or a first-generation antihistamine, 4.6% regularly used the long-acting benzodiazepines nitrazepam or flunitrazepam, while 6.9% were issued an NSAID in a potentially harmful combination with warfarin, a diuretic, an SSRI or an ACE inhibitor. During a 3-month period, 2.8% of the patients used three or more psychotropic drugs simultaneously.
In total, 15,790 patients (18.4%) had been issued one or more PIPs during the 1-year period; 72.9% received one, 19.6% two, 5.3% three, and 2.2% four or more different PIPs. Female patients comprised 66% of the sample, with a mean age of 79.8 years (S.D. 6.4 years). For male patients, the mean age was 78.7 years (S.D. 6.0). There were no significant differences regarding sex or age for patients receiving one, as compared with more than one, inappropriate prescription.
One-third of the 454 GPs were women who also tended to be somewhat younger than the male GPs, and more of whom had not attained specialist competence in general practice. The female GPs also had a lower prescribing activity, that is, they wrote fewer prescriptions per patient ≥70 years of age. In a bivariate analysis, we found that being a female GP, working in a group practice, not having completed vocational training, having worked only a short time since being licensed, and having prescribed for relatively few patients aged ≥70 years, predicted a more appropriate prescribing practice.
In a regression model, the sex of the doctors lost significance, while having a short period of experience since obtaining a medical licence, not yet being a GP specialist, working in a group practice and having few older patients still correlated with a lower proportion of PIPs, that is, older GPs prescribed more PIPs than their younger colleagues did (table 4). Table 4 shows that having worked ten years longer in practice implicates 2.6 additional inappropriate prescriptions.
The Prescription Peer Academic Detailing Intervention

Method.
The prescription peer academic detailing (Rx-PAD) study was a cluster-randomized trial on peer CME groups, which were randomized to receive either a tailored intervention to reduce inappropriate prescriptions to patients ≥70 years [5], or a tailored intervention to support a more rational prescribing of antibiotics [49] . Cluster-randomized trials are more complex to design, require more participants and require more complex analyses, primarily because observations on individuals within the same cluster may be correlated. The sample size considers the need to adjust for intracluster correlation, which is a consequence of randomizing at one level (CME groups) and analysing at another (patients). The GPs' prescribing of PIPs was analysed based on prescription data from the NorPD [4] for the year before the intervention and for 1 year after the intervention. The patients' identities were extracted from the GPs' Electronic Patient Record (EPR). The GPs' prescribing was measured for potential inappropriateness against 24 explicit criteria, which were all rated as highly clinically relevant and were all included in the original 37 criteria from the start of the Delphi process. The flow chart of the Rx-PAD study is shown in fig. 1 .
Material.
Participation in a number of peer group meetings as a part of the CME programme is required to retain the specialization in general practice in Norway. Typically, a peer CME group is comprised of seven to eight GPs who set up their own educational programme for monthly evening meetings. Based on lists provided by the Norwegian Medical Association, peer CME groups in southeast Norway (250 groups) were invited, of which 81 groups (comprising 465 GPs) accepted the invitation.
The randomization of the CME groups was stratified by five geographical regions to reconcile the number of available tutors needed for each arm of the study within each region. Within each stratum, the CME group number and the number of GPs involved in the project were standardized. The allocation sequence was random and blinded for the investigators. It was based on clusters (CME groups), and the sequence was concealed until the interventions had been assigned. Based on this randomization, the CME groups were allocated to the 'intervention arm' or the other study arm, which was the 'antibiotic arm' [49] . The two groups were respective controls for each other.
Data.
Data were captured from two main sources: the EPRs and the NorPD. From the GPs' EPR system, information about patients -age, consultation data and GP identity -was extracted. Mediata Ltd. had developed a software tool for the purpose. This extraction programme was distributed on a compact disc (CD) to all participating GPs ahead of the study. The GPs did the data extraction and returned the encrypted extracted data to the research centre on floppy discs. The dataset from NorPD provided data on the drugs actually dispensed in terms of the anatomical, therapeutic and chemical (ATC) classification system with DDDs (i.e. the ATC/DDD system) [50] . Prescriptions from each GP were linked to their unique patients.
Baseline data (from all 454 GP participants) were based on the GPs' complete prescription data from year 2005. The second data capture covered the period of 1 July 2006-30 June 2007. The intervention consisted of three elements: CME meetings (AD), feedback reports and regional workshops.
Visits by Peer academic detailers (PADs).
Prior to the main study, a pilot study was carried out involving 13 physicians -peer academic detailers (PADs) -each with responsibility for the intervention in about three peer CME groups. Before the intervention, the PADs received two training sessions each of 2 days. The sessions focused on safety issues in relation to pharmacological treatment of older people, pedagogical intervention techniques and how to use the software for extracting data files from the EPRs. The PADs had two assignments: (1) to present the principles for safe prescribing practice for older patients and (2) to facilitate the audit and discussion in the CME group meetings. The tailored intervention included three visits by a PAD to each CME group, the first two of which were part of the intervention [5] . A final visit at the end of the trial was added to summarize GPs' individual achievements and to identify any possible needs for further quality improvement work.
In the first visit, the PADs presented main elements of the intervention with special emphasis on safe prescription strategies and possible harmful effects of particular drugs and combinations of drugs. This included the rationale for the 13 PIP criteria used as main outcome measures in the trial. Participants received instructions for capturing data from their own EPR systems.
Between the first and the second meeting, and based on the captured EPR-data linked with corresponding NorPD prescription data, each participating GP received an individual report reflecting their baseline prescription practice for elderly patients. The individual report described each GP's number of 'hits' according to the listed criteria and as compared with average figures for all participating GPs. For each criterion, the feedback report also provided suggestions for safer, alternative therapeutic options. The second visit took place about 2 months after the first one and focused on the GPs' individual prescription patterns as reflected in the prescription report. The PADs facilitated the discussion within the CME group where each GP described his/her prescription pattern and discussed own potentials for improvement with the group. The 'triad technique' was applied for this discussion in the groups. This technique was first described by Agyris [51] and implies a discussion within a group of three members: one is the 'owner' of the results to be discussed, the second is the 'opponent', while the third is the observer. The roles alternate between the three participants. Finally, the results were discussed in a plenary session. In this way, the GPs had to disclose their results to their colleagues. Three months after the second visit, all participating GPs gathered in regional full-day workshops chaired by two of the authors. In these workshops, the rational pharmacological treatment for patients aged ≥70 years was outlined in more depth.
Twelve months after the educational intervention and after the observation period, a new data capture was carried out, and the GPs received a second feedback report. In this report, they received information about their prescribing of PIPs after the intervention, as compared with their baseline data. A third AD visit was then carried out as an 'extra service' to the participating GPs. Here, the change in each GP's prescription patterns was discussed in the same way as during the previous meeting. This third AD visit was not part of the intervention and it was not mentioned in the protocol [5] .
Statistics.
The Rx-PAD study was a cluster-randomized trial where the clusters were the GPs' CME groups. From the pilot study (with 13 GPs), the mean number of PIPs per 100 older patients during the preceding 12 months was 25. An estimated clinically relevant reduction from 25 to 17 'hits' per 100 patients (32% relative reduction), adjusted for changes in the control group, implied a need for 74 peer CME groups (power of 80%, level of significance of 5% and adjusted for intracluster correlation). We assumed that the average number of GPs per peer group was 7.5 (allowing for some drop-outs) and that the average number of patients aged ≥70 years per GP during the study period would be 165.
The power estimate was actually calculated for the antibiotic arm [49] based on an intracluster coefficient (ICC) from a comparable study [52] . With this assumed ICC of 0.085 for clustering within the CME groups, an assumed number of patients (≥70 years) of 165 per GP and 7.5 GPs per CME group, the number of patients needed in each arm after accounting for the ICC, was 43,077. Dividing this again between GPs and then peer CME groups, we calculated a need for at least 35 peer CME groups in each trial arm. The estimated residual ICC was calculated after the intervention.
When analysing the material, we partly used descriptive statistics and logistic regression models. Whenever applicable, we adjusted for clustering effects at the CME group level to compensate for any possible effect of co-ordinated prescribing practices within the CME groups.
The outcome measures were the reduction of PIPs per 100 prescriptions, the reduction of PIPs per 100 patients and the reduction of number of patients exposed to one or more PIPs in the intervention group compared with the control group.
Subgroup analyses were undertaken based on the GPs' sex, age, whether GP specialist or not, urban or rural practice, group practice or single-handed practice, prevalence of PIPs at baseline and prescribing activity (i.e. number of prescriptions issued by the GP) in the pre-intervention 1-year period.
Data on rates of PIPs, defined as the number of PIPs per 100 prescriptions, were analysed using the Poisson regression model. All analyses were performed in Stata SE 13.
Results
Of the 250 invited CME groups, 81 (465 GPs) agreed to participate. The CME groups were randomized aiming for two equally sized trial arms: (1) an educational intervention on safer prescribing for older patients (i.e. this trial; 41 CME groups) and (2) an educational intervention to promote more rational use of antibiotics for upper respiratory tract infection (URTI) (i.e. the control group for this study: 41 CME groups) ( fig. 1 ). As some GPs were lost to follow-up and two CME groups were merged into one, the results are based on 250 GPs (41 CME groups) in the intervention group and 199 GPs (39 CME groups) in the control group ( fig. 1) .
The results showed that in total, 1,034,034 prescriptions were issued for 81,810 patients ≥70 years of age before the intervention and 1,104,391 prescriptions for 80,521 patients after the intervention. In the intervention group, 46,737 patients aged ≥70 years were issued prescriptions, of which 9278 (19.6%) received one or more prescriptions that met our criteria for potential pharmacological inappropriateness. Compared with the control group, PIPs per 100 patients were reduced by 3.3% (absolute); the relative reduction (95% CI) was 12.1% (6.9%-16.8%). The number of patients receiving one or more inappropriate prescriptions was reduced by 1173; that is, the absolute risk reduction was 1.6% and the relative reduction 8.1%. PIPs per 100 prescriptions were reduced by 13.0% (8.6%-17.3%) (table 5).
The greatest average reduction (95% CI) was seen for firstgeneration antipsychotics: À24.1% (À41.3 to À10.3%) and the combination of NSAIDs and warfarin: À33.3% (À66.6 to À16.7%). A non-significant reduction in PIPS was seen for the concomitant prescribing of three or more psychotropic drugs: À4.0% (À16.8 to 8.0%).
Discussion
Criteria for PIPS (the NorGeP criteria).
After three rounds of the Delphi process, consensus was achieved for 36 criteria (the NorGeP criteria). The aim of the process was not to address all possible drug-related problems, but rather to present a short list that included some important prescriptions that should be avoided for older patients whenever possible. The listed criteria may also be regarded as a selection of examples, illustrating reasons and mechanisms for inappropriateness that may also be relevant for other drugs and drug-drug combinations. The NorGeP criteria should, therefore, not be regarded as a complete list of PIPs to older patients. Certainly, other criteria might also have reached consensus among the panellists, but the list could then easily have become too extensive and not feasible for use in general practice.
Our panel included more participants than is commonly used, suggesting that the reliability of the NorGeP study is high. We consider the NorGeP criteria to be an important tool in identifying problem areas of prescribing at group level [53] . GPs may also find the list useful as a support tool during medication list reviews for their own patients and in their decision-making process when prescribing drugs to older patients. However, such criteria lists need a continuous update.
Prevalence of PIPs to patients ≥70 years. We found that 15,790 patients (18.4%) of patients aged ≥70 years received one or more PIPs. The prevalence rate of PIPs was 24.7 PIPs per 100 patients ≥70 years. These results are in line with the results of other studies [11, 26, 27] who also have reported high prevalence of PIPs despite using different criteria. The fact that relatively older GPs were positively correlated with a more inappropriate pattern of prescription may be explained by the fact that they, probably more than their younger peers, were used to prescribe 'older' first-generation drugs that, to a large extent, were targeted by our PIP criteria. It is likely that recent medical education has introduced more updated treatment alternatives. Each period of 10 years or longer in practice resulted at an average in 2.6 additional PIPs per 100 patients aged ≥70 years (table 4) .
This baseline study nevertheless supports the relevance of selecting the chosen PIP criteria and the main outcome measures in the following educational intervention trial.
The prescription peer academic detailing intervention. The Rx-PAD study is one of the largest educational intervention studies undertaken in Norwegian general practice, including approximately 10% of all Norwegian GPs. The study also had an extraordinarily high completion rate (96.5%), and the participating GPs felt that it had strong clinical relevance [54] . These factors, together with the completeness of the prescription data, all strengthen the study results.
This large multifaceted educational intervention in peer CME groups resulted in fewer PIPs to older patients. Even though the effects may seem moderate, we consider that the reduction of PIPs by 12.1% is clinically important and relevant (table 5). The outcome that the GPs in the control group (i.e. those allocated to the antibiotic intervention [55] ) also improved their prescribing practice to older patients, probably We performed a subgroup analysis to assess the characteristics of the GPs who responded to the intervention. We intend to publish these data in a separate paper not included in this thesis. Briefly, we found that improvements in prescribing after intervention were highest among GPs in the oldest group, among GPs with 2.4-2.9 PIPs per 100 prescriptions at baseline and GPs with at least 15 prescriptions per patient at baseline. 1 PIP denotes potentially inappropriate prescription. 2 Adjusted for baseline differences and intracluster effect. 3 Total number of prescriptions issued for patients aged ≥70 years during baseline and follow-up periods, respectively. 4 Absolute change denotes differences between figures from before and after the intervention, while relative change represents this difference relative to the baseline figures.
represent a Hawthorne effect in response to the fact that they knew that they were being studied [56] . The design of our study, and of similar studies, may thus under-estimate the effects due to the intervention. The effect of the intervention is likely to be influenced by the choice of PIP criteria, not only because of the different prevalence of the various criteria, but also because of the different levels of agreement between GPs about the criteria. Non-controversial criteria are more likely to be followed than controversial guidelines, which may represent a barrier to adherence [57] . Likewise, the GPs' questioning of the guidelines, and their evidence-based applicability, may also be a barrier to adherence [58] . The results of this study might have been different if more controversial criteria for inappropriateness had been chosen. The fact that an effect of the intervention was found for almost all outcome measures also indicates the robustness of this method.
The largest reductions, compared with baseline, were seen for drugs with strong anticholinergic properties, such as tricyclics, 'old' antihistamines and 'old' antipsychotics. For example, the GPs' prescribing of tricyclic antidepressants declined by 16.7%. It may seem paradoxical that even if the reduction in concomitant prescribing of three or more psychotropic drugs was rated as highly relevant by all the panel specialists in the Delphi study, no reduction in this PIP criterion was found due to the intervention. This might indicate that, for some drugs, or in some contexts, barriers to improve prescribing may be difficult to overcome. It may also reflect an expanding market for newer psychopharmaceuticals. We therefore conclude that the effect of an educational intervention depends to a high degree on the PIP criteria used as outcome measures. However, studies, such as ours, that apply different criteria targeting a broad spectrum of therapeutic groups, will be less likely to be influenced by the criteria chosen and may therefore have a greater external validity with respect to the educational method used during the intervention.
We calculated the sample size needed for this trial based on the ICC of 0.085, which was used in another Norwegian cluster-randomized educational intervention [52] . The ICC accounts for the relatedness of clustered data by comparing the variance within clusters with the variance between clusters [59] . However, the study referred to above was randomized at the level of GP practices and focused on antibiotic prescribing for urinary tract infections, which is a clinical procedure that is more likely to be standardized at the practice level [52] . It is, therefore, not surprising that in our study we found a lower ICC (0.045) which also implies that our sample size was more than sufficient.
We have found few other general practice-based studies with comparable design to ours that have investigated the effects of a broad spectrum of PIP criteria. A 2009 review included 24 studies of interventions aimed at reducing inappropriate prescriptions to older patients [60] . Only four studies were educational interventions, two of which targeted limited therapeutic areas such as a reduction in the prescription of long-acting benzodiazepines to older people [61] or of inappropriate prescribing of proton pump inhibitors [62] . Only one study examined the effect of interventions on overall prescribing quality [63] but that study lacked a control group. Due to its size (large numbers of participating GPs) and scope (addressing prescribing quality across multiple therapeutic areas), we believe that our study represents an important contribution to the knowledge about educational interventions in general practice. An Irish study has later on reported a significant reduction in PIPs after a multifaceted educational intervention incorporating AD [64] . The OPTI-SCRIPT study focused on fewer therapeutic areas than we did, but the results are consistent with our findings [55] .
The fact that GPs with a relatively high prevalence of PIPs at baseline (i.e. in the pre-intervention period) showed the greatest improvement is consistent with the findings of Jamtvedt et al. [36] : 'the absolute effect of audit and feedback is more likely to be larger when the baseline adherence to the recommended practice is low'.
There are certain characteristics of this intervention that may have influenced the result. The participating GPs knew that their results would be revealed in the CME group, and they may have made extra efforts to improve their own practice, and of course, the worse the starting point, the greater the potential for improvement. We found no differences in the improvement in prescribing between GPs working singlehanded or in group practices.
Conclusions
Our study showed that a model combining AD with audit and feedback, using GPs as academic detailers, could reduce inappropriate prescribing among GPs. We therefore recommend this model for future quality improvement work in general practice.
Criteria for inappropriate prescriptions in general practice will need continuous updating and revision. Future interventions to improve prescribing practice should also aim to include patient-related outcome data like quality of health and cost-effectiveness analyses of the results. This is necessary for investigating long-term effects of intervention studies like this one. A cluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practice-the prescription peer academic detailing (Rx-PAD) study
